Medicine
Leukotrap RC PL System 3.57 g/70 mL injection
Leukotrap RC PL System 3.57 g/70 mL injection is a prescription medicine containing Dextrose, unspecified form for intravenous use, marketed by Gvs Tm, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at room temperature, avoid excessive heat, protect from freezing.
Key facts
- Active ingredient (INN)
- Dextrose, unspecified form
- Brand
- Leukotrap RC PL System
- Strength
- 3.57 g/70 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 6 pouches of 70 mL
- Marketing authorisation holder
- Gvs Tm
- Manufacturer
- Gvs Tm
- Origin register
- US FDA, United States
- Storage
- Store at room temperature, avoid excessive heat, protect from freezing.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 23 June 2026
- Identifiers
- DailyMed set ID 54eb0462-cd00-4467-e063-6394a90aa371, 54eab581-bc48-f9f0-e063-6394a90a4b93, 54e9a497-7a94-44c9-e063-6294a90a84daNDC 87069-123Application BN820915
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Dextrose, unspecified form 3.57 g/70 mL injection.
Other strengths and forms of Dextrose, unspecified form
Clinical summary
Dextrose, unspecified form is a prescription medicine indicated as a source of water and calories in adult, among other approved uses. MedsAcross supplies Dextrose, unspecified form for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Dextrose, unspecified formFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- DEXTROSE prescribing information (B. Braun Medical) · U.S. National Library of Medicine, DailyMed
Need Leukotrap RC PL System 3.57 g/70 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.